China Lung Cancer Diagnostics Market to 2032
Overview
The China Lung Cancer Diagnostics Market is expected to reach a 595.58 USD Billion by 2032 and is projected to grow at a CAGR of 28.27% from 2025 to 2032.
Revenue, 2024 (USD Billion)
143.22
Forecast, 2032 (USD Billion)
595.58
CAGR, 2024 - 2032
28.27%
Report Coverage
China
China Lung Cancer Diagnostics Market 2018-2032 USD Billion
China Lung Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 143.22 USD Billion
- Projected Market Size (2032): 595.58 USD Billion
- CAGR (2025-2032): 28.27%
Key Findings of China Lung Cancer Diagnostics Market
- The China Lung Cancer Diagnostics Market was valued at 143.22 USD Billion in 2024.
- The China Lung Cancer Diagnostics Market is likely to grow at a CAGR of 28.27% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Non-Small Cell Lung Cancer in Cancer Segment accounted for the largest share of the market with a revenue of 109.02 USD Billion
- The fastest growing segment Hospital in End User Segment grew Fastest with a CAGR of 31.43% during the forecast period from 2024 to 2032.
China Lung Cancer Diagnostics Market Scope
China Lung Cancer Diagnostics Market Segmentation & Scope
Product
- Consumables & Accessories
- Instruments
Test
- Others
- Blood Test
- Biopsy
- Biomarkers Test
- Imaging Test
End User
- Others
- Cancer Research Institutes
- Diagnostic Imaging Centers
- Independent Diagnostic Laboratories
- Associated Labs
- Hospital
Cancer
- Small Cell Lung Cancer
- Non-Small Cell Lung Cancer
Distribution Channel
- Retail Sales
- Direct Tender
China Lung Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 143.22 USD Billion |
| Market Value in 2032 | 595.58 USD Billion |
| CAGR (2025-2032) | 28.27% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product,Test,End User,Cancer,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): China, leading in terms of revenue 143.22 USD Billion in 2024
- Key Country: China, leading in terms of revenue with value of 143.22 USD Billion in 2024.
Segments and Scope
-
China Lung Cancer Diagnostics Market to 2032, By Product
- Instruments is the largest segment in China Lung Cancer Diagnostics Market to 2032 with a revenue of 89.46 USD Billion in the year 2024.
- Instruments is the Fastest growing segment in China Lung Cancer Diagnostics Market to 2032 with a Growth rate of 29.35 % in forecast period 2025-2032.
-
China Lung Cancer Diagnostics Market to 2032, By Test
- Imaging Test is the largest segment in China Lung Cancer Diagnostics Market to 2032 with a revenue of 68.10 USD Billion in the year 2024.
- Imaging Test is the Fastest growing segment in China Lung Cancer Diagnostics Market to 2032 with a Growth rate of 29.62 % in forecast period 2025-2032.
-
China Lung Cancer Diagnostics Market to 2032, By End User
- Hospital is the largest segment in China Lung Cancer Diagnostics Market to 2032 with a revenue of 34.46 USD Billion in the year 2024.
- Hospital is the Fastest growing segment in China Lung Cancer Diagnostics Market to 2032 with a Growth rate of 31.43 % in forecast period 2025-2032.
-
China Lung Cancer Diagnostics Market to 2032, By Cancer
- Non-Small Cell Lung Cancer is the largest segment in China Lung Cancer Diagnostics Market to 2032 with a revenue of 109.02 USD Billion in the year 2024.
- Non-Small Cell Lung Cancer is the Fastest growing segment in China Lung Cancer Diagnostics Market to 2032 with a Growth rate of 28.56 % in forecast period 2025-2032.
-
China Lung Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in China Lung Cancer Diagnostics Market to 2032 with a revenue of 77.86 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in China Lung Cancer Diagnostics Market to 2032 with a Growth rate of 29.77 % in forecast period 2025-2032.
China Lung Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| Quest Diagnostics Incorporated | |||
| Bio-Rad Laboratories, Inc. | |||
| Abbott | |||
| Guardant Health | |||
China Lung Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion
China Lung Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The China Lung Cancer Diagnostics Market is segmented based on Segmentation Product,Test,End User,Cancer,Distribution Channel.
China Lung Cancer Diagnostics Market was valued at USD 143.22(Revenue in USD Billion) in 2021.
China Lung Cancer Diagnostics Market is projected to grow at a CAGR of 28.27% during the forecast period of 2024 to 2032.
The Non-Small Cell Lung Cancer segment is expected to dominate the China Lung Cancer Diagnostics Market, holding a largest market share of 109.02 USD Billion in 2024
China Lung Cancer Diagnostics Market Scope
China Lung Cancer Diagnostics Market Segmentation & Scope
Product
- Consumables & Accessories
- Instruments
Test
- Others
- Blood Test
- Biopsy
- Biomarkers Test
- Imaging Test
End User
- Others
- Cancer Research Institutes
- Diagnostic Imaging Centers
- Independent Diagnostic Laboratories
- Associated Labs
- Hospital
Cancer
- Small Cell Lung Cancer
- Non-Small Cell Lung Cancer
Distribution Channel
- Retail Sales
- Direct Tender
Frequently Asked Questions
The China Lung Cancer Diagnostics Market is segmented based on Segmentation Product,Test,End User,Cancer,Distribution Channel.
China Lung Cancer Diagnostics Market was valued at USD 143.22(Revenue in USD Billion) in 2021.
China Lung Cancer Diagnostics Market is projected to grow at a CAGR of 28.27% during the forecast period of 2024 to 2032.
The estimated market value of the China Lung Cancer Diagnostics Market for final year is USD 595.58 (USD Billion).
China Lung Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The China Lung Cancer Diagnostics Market is segmented based on Segmentation Product,Test,End User,Cancer,Distribution Channel.
China Lung Cancer Diagnostics Market was valued at USD 143.22(Revenue in USD Billion) in 2021.
China Lung Cancer Diagnostics Market is projected to grow at a CAGR of 28.27% during the forecast period of 2024 to 2032.
The estimated market value of the China Lung Cancer Diagnostics Market for final year is USD 595.58 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.